Jack Nielsen

Jack Nielsen General Information

Biography

Mr. Jack Bech Nielsen serves as Board Member at Ocelot Bio. He serves as Board Member at Inspirna. He serves as Managing Partner at Vivo Capital. He serves as the Chairman at Aligos Therapeutics. He served as Board Member at Apollo, IO Biotech, Unchained Labs, Anokion, Kanyos Bio, and PROCEPT BioRobotics. He also served as a Partner at Novo Ventures at Novo Holdings. He served as Board Member at ALX Oncology, Reata Pharmaceuticals and MacuLogix. Since 2001, Mr. Nielsen has been employed by Novo A/S, the holding company of the Novo Group, wholly owned by the Novo Nordisk Foundation, which manages the foundation's financial assets through investments in the life science industry, where he currently serves as a Senior Partner. From 2006 to 2012, Mr. Nielsen was employed as a Partner at Novo Ventures (US) Inc. in San Francisco, a wholly-owned subsidiary of Novo A/S. He is a member of the board of directors of two publicly listed companies, Reata Pharmaceuticals Inc. and Merus N.V. Mr. Nielsen holds an M.Sc. in chemical engineering from the Technical University of Denmark and an M.S. in management of technology from the Technical University of Denmark. Apollo believes Mr. Nielsen's qualifications to serve on the board of directors include his extensive experience in venture capital and the medical technologies industry. He serves as Board Member at Clasp Therapeutics. Nielsen is a Managing Partner of Vivo Capital. Prior to joining Vivo, Jack worked within the Novo A/S organization and its venture activities since 2001 in several roles, most recently as a Senior Partner. From 2006 to 2012, Jack was employed as a Partner at Novo Ventures (U.S.), Inc. in San Francisco, where he established the firm's U.S. office. Jack currently serves as a member of the Board of Directors of Aligos Therapeutics, ALX Oncology, Harmony Biosciences, Instil Bio and IO Biotech. He previously served on the board of directors of publicly-traded companies Reata Pharmaceuticals, Akebia Therapeutics Inc., Merus, B.V and Apollo Endosurgery, Inc. He was also a member of the boards of directors of a number of private companies including Alios Biopharma, Anokion, NeoMend, Procept Biorobotics, ProteinSimple, Tobira Therapeutics and Unchained Labs.